Health Care

Avendus Capital has considerable experience and a strong network of global relationships in the Health Care sector. The Health Care Group consists of professionals with many years of investment banking and operating experience in the industry.

The Group delivers strategic financial advisory to clients across the spectrum of Health Care, Specialty Chemicals, and Agro Chemicals sub-sectors, including the following sub-segments:

  • Pharmaceutical Drugs

    Including Branded Formulations, Generics, Ethical Drugs, Bio-Pharmaceuticals and Vaccines

  • Contract Research & Manufacturing Services (CRAMS)

    Including Clinical Research (CROs)

  • Hospitals and Pathology Labs

  • Medical Technology

    Including diagnostic equipment and medical devices

To know more about the Health Care group, write to

Key Transactions

July 2017
Avendus advises Paras Healthcare in raising INR 275 crores from Creador LLP
September, 2015
The Carlyle Group has acquired a minority stake in Metropolis Healthcare Ltd
September, 2011
Avendus advises Eris Lifesciences on its private equity transaction with ChrysCapital
March, 2011
Avendus advises the shareholders of Devidayal Sales in a strategic transaction with Arysta LifeScience
October, 2010
Avendus advised shareholders of Accutest to sell controlling stake to the PE fund, Greater Pacific Capital
August, 2010
Sole advisor to Lambda Therapeutic Research in its acquisition of Biovail's Contract Research Division
August, 2010
Advisor to Famy Care on a transaction in which AIF Capital acquired a minority stake
July, 2008
Eastgate Capital Group invests INR 100 Crore in Avendus Capital
Sole advisor to JB Chemicals and Pharmaceuticals Ltd. for a strategic stake in Biotech (an South Africa based Pharma company)
Sole advisor to Sanmar for the sale of its API division to Actavis
Read more
February, 2007
Sole advisor to Ranbaxy for its stragetic investment in Krebs
Read more

Transaction Finder